Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of cell type specific ACE2 modifiers by CRISPR screening. | PLoS Pathog | 2022 | 35231079 | PubTator, text mining | PubMed |
| Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors. | Viruses | 2022 | 35215976 | PubTator, text mining | PubMed |
| Genetic Factors of Renin-Angiotensin System Associated with Major Bleeding for Patients Treated with Direct Oral Anticoagulants. | Pharmaceutics | 2022 | 35213964 | PubTator, text mining | PubMed |
| Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research. | Int J Environ Res Public Health | 2022 | 35206610 | PubTator, text mining | PubMed |
| Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model. | Diagnostics (Basel) | 2022 | 35204354 | PubTator, text mining | PubMed |
| The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells. | Cells | 2022 | 35203286 | PubTator, text mining | PubMed |
| Identification of Synovial Fibroblast-Associated Neuropeptide Genes and m6A Factors in Rheumatoid Arthritis Using Single-Cell Analysis and Machine Learning. | Dis Markers | 2022 | 35186167 | PubTator, text mining | PubMed |
| The autonomic aspects of the post-COVID19 syndrome. | Autoimmun Rev | 2022 | 35182777 | PubTator, text mining | PubMed |
| Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression. | J Integr Neurosci | 2022 | 35164461 | PubTator, text mining | PubMed |
| In Silico Analysis of Metabolites from Peruvian Native Plants as Potential Therapeutics against Alzheimer's Disease. | Molecules | 2022 | 35164183 | PubTator, text mining | PubMed |
| Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders. | Molecules | 2022 | 35163934 | PubTator, text mining | PubMed |
| Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents. | J Alzheimers Dis | 2022 | 35147539 | PubTator, text mining | PubMed |
| Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35130610 | PubTator, text mining | PubMed |
| Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1. | Oxid Med Cell Longev | 2022 | 35126818 | PubTator, text mining | PubMed |
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study. | Mol Biol Rep | 2022 | 35102475 | PubTator, text mining | PubMed |
| A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis. | Curr Res Physiol | 2022 | 35098155 | PubTator, text mining | PubMed |
| Human pluripotent stem cell-derived functional sympathetic neurons express ACE2 and RAAS components: a framework for studying the effect of COVID-19 on sympathetic responsiveness. | Clin Auton Res | 2022 | 35091835 | PubTator, text mining | PubMed |
| Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. | JAMA Netw Open | 2022 | 35089354 | PubTator, text mining | PubMed |
| Comparative study of SARS-CoV-2 infection in different cell types: Biophysical-computational approach to the role of potential receptors. | Comput Biol Med | 2022 | 35077937 | PubTator, text mining | PubMed |
| COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives. | Int J Mol Sci | 2022 | 35054906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=21